Gloria M. Mccarthy - 01 Mar 2023 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Reporting relationship: EVP & Chief Administrative Off
Issuer ticker: ELV
Reported as of: 01 Mar 2023
Net transaction value: -$2,834,867
SEC form: 4
Accepted by SEC: 03 Mar 2023, 15:22:05 UTC
Prior SEC filing: 03 Mar 2022
Next SEC filing: 27 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Kathleen S. Kiefer, Attorney in fact

Key filing fact

Gloria M. Mccarthy filed Form 4 for Elevance Health, Inc. (ELV) on 03 Mar 2023.

Key facts

This page summarizes Gloria M. Mccarthy's Form 4 filing for Elevance Health, Inc. (ELV).
5 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2023, 15:22.

Change

Previous filing in this sequence was filed on 03 Mar 2022.
Current net transaction value: -$2,834,867.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELV transaction

Common Stock

Tax liability

Transaction value: $289,392
Shares: -617
Change %: -1%
Price: $469.03
Shares after: 60,114
Date: 01 Mar 2023
Ownership: Direct
Footnotes: F1

ELV transaction

Common Stock

Award

Transaction value: $0
Shares: +2,133
Change %: +3.5%
Price: $0.000000
Shares after: 62,247
Date: 01 Mar 2023
Ownership: Direct
Footnotes: F2

ELV transaction

Common Stock

Award

Transaction value: $0
Shares: +9,716
Change %: +16%
Price: $0.000000
Shares after: 71,963
Date: 01 Mar 2023
Ownership: Direct
Footnotes: F3

ELV transaction

Common Stock

Tax liability

Transaction value: $2,545,475
Shares: -5,430
Change %: -7.5%
Price: $468.78
Shares after: 66,533
Date: 02 Mar 2023
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELV transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +8,195
Change %
Price: $0.000000
Shares after: 8,195
Date: 01 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,195
Exercise price: $469.03
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Footnote F2

Represents restricted share units. Restrictions lapse as follows: 711 shares each on 3/1/2024, 3/1/2025 and 3/1/2026.

Footnote F3

Represents performance based restricted share units. Restrictions lapse on 3/2/2023.

Footnote F4

The option represents a right to purchase a total of 8,195 shares, and is exercisable in one installment of 2,731 and two installments of 2,732 shares each, beginning on 3/1/2024 which is the one-year anniversary of the option grant date.